Older Hispanic people are "disproportionately more likely" than older White people to develop Alzheimer's, research shows
Older Hispanic adults in the US are about one and a half times more likely to have Alzheimer's or other dementias than their White peers, according to the Alzheimer's Association's annual special report.
1970-01-01 08:00
Major US health systems expect to offer Alzheimer's drug Leqembi in a few months
By Julie Steenhuysen and Deena Beasley CHICAGO Five major U.S. health systems said they would offer Eisai and
1970-01-01 08:00
Quest Diagnostics launches Alzheimer's blood test for consumers
By Julie Steenhuysen CHICAGO (Reuters) -Quest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of
1970-01-01 08:00
US announces trial payment program for care providers of dementia patients
The U.S. government said on Monday it would trial a new payment program for people who provide dementia
1970-01-01 08:00
Promising new Alzheimer's drugs may benefit whites more than Blacks
By Julie Steenhuysen NEW YORK Groundbreaking treatments for Alzheimer's disease that work by removing a toxic protein called
1970-01-01 08:00
Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial
By Deena Beasley (Reuters) -Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the
1970-01-01 08:00
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
By Julie Steenhuysen Alzheimer's disease experts are revamping the way doctors diagnose patients with the progressive brain disorder
1970-01-01 08:00
Acumen's Alzheimer's drug passes initial safety test
By Julie Steenhuysen CHICAGO An experimental Alzheimer's disease drug developed by Acumen Pharmaceuticals targeting a novel form of
1970-01-01 08:00
Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug
Eisai Co Ltd and Biogen Inc's Leqembi emerged as the first Alzheimer's treatment to win the U.S. Food
1970-01-01 08:00
Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?
By Deena Beasley The U.S. Food and Drug Administration on Thursday granted standard approval to Eisai and Biogen's Leqembi for
1970-01-01 08:00
US FDA grants standard approval of Eisai/Biogen Alzheimer's drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -The U.S. Food and Drug Administration on Thursday granted standard approval
1970-01-01 08:00
Medicare offers details on reimbursement for new Alzheimer's drugs
By Julie Steenhuysen CHICAGO (Reuters) -The U.S. Medicare health plan on Thursday offered details of plans to collect patient data
1970-01-01 08:00